EIS
Price
Price
CHART BY
Historical dividends and forecast
EIS has so far distributed $0.0386 in 2026. The next dividend will be paid on 08.05.2027
CHART BY
Frequently asked questions
What is EIS's market capitalization?
What is EIS's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for EIS?
What are the analyst ratings and target price for EIS's stock?
What is EIS's revenue over the trailing twelve months?
What is the EBITDA for EIS?
What is the free cash flow of EIS?
How many employees does EIS have, and what sector and industry does it belong to?
What is the free float of EIS's shares?
Financials
- Market Cap
- TRY 59.89B
- EPS (TTM)
- $2.702
- Free Float
- 128.61M
- P/E ratio (TTM)
- 28.67
- Revenue (TTM)
- TRY 9.42B
- EBITDA (TTM)
- TRY 544.90M
- Free Cashflow (TTM)
- TRY 1.88B
Pricing
- 52W span
- $1.018$3.054
Analyst Ratings
The price target is TRY 3.269 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS is a holding company, which engages in the investment and management business. It operates through the Health and Real Estate Development segments. The Health segment is the production and sale of human health and veterinary medicine. The Real Estate Development segment is the sale and lease of properties and lands. The company was founded by Mehmet Nejat Eczacibasi, Melih Eczacibasi, Haluk Eczacibasi, Kemal Eczacibasi, and M. Sakir Eczacibas on October 24, 1951 and is headquartered in Istanbul, Turkey.
- Employees
- 1,071
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- TRAECILC91E0
- Primary Ticker
- ECILC.E